Amend Amendment No. 2 by Leach to SB 2024 on page 2 of the amendment by striking lines 21 through 24 and substituting the following:
(2) the manufacturer:
(A) holds for the manufacturer's e-cigarettes a marketing authorization or similar order issued by the United States Food and Drug Administration under 21 U.S.C. Section 387j; or
(B) has timely filed with the United States Food and Drug Administration under 21 U.S.C. Section 387j a premarket tobacco product application for the manufacturer's e-cigarettes that:
(i) is under review by the United States Food and Drug Administration; or
(ii) has received a denial order that is stayed, rescinded, or vacated by the United States Food and Drug Administration or a court order, as applicable; and